495
Views
35
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Meta-analysis: Fact or fiction? How to interpret meta-analyses

, , , , &
Pages 188-200 | Received 15 Oct 2010, Accepted 22 Dec 2010, Published online: 04 Mar 2011

References

  • Ades AE, Lu G, Higgins JPT. 2005. The interpretation of random-effects meta-analysis in decision models. Med Decis Making 25:646–654.
  • Bandelow B, Zohar J, Kasper S, Möller HJ. 2008. How to grade categories of evidence. World J Biol Psychiatry 9:242–247.
  • Bennett DA. 2001. How can I deal with missing data in my study? Aust NZ J Public Health 25:464–469.
  • Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JPT, Churchill R, . 2009. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373:746–758.
  • Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale. Lawrence Erlbaum Associates, Inc.
  • Duval S, Tweedie R. 2000. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463.
  • Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634.
  • Fountoulakis KN, Möller HJ. 2010. Efficacy of antidepressants: a re-analysis and reinterpretation of the Kirsch data. Int J Neuropsychopharmacol 1–8.
  • Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, . 2010. Antidepressant drug effects and depression severity: a patient-level metaanalysis. J Am Med Assoc 303:47–53.
  • Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. 2006. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59:7–10.
  • Garg AX, Hackam D, Tonelli M. 2008. Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3:253–260.
  • Geddes JR, Calabrese JR, Goodwin GM. 2009. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194:4–9.
  • Gelfand LA, Strunk DR, Tu XM, Noble RES, Derubeis RJ. 2006. Bias resulting from the use of ‘assay sensitivity’ as an inclusion criterion for meta-analysis. Stat Med 25:943–955.
  • Hammad TA, Laughren T, Racoosin J. 2006. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63:332–339.
  • Hansen RA, Moore CG, Dusetzina SB, Leinwand BI, Gartlehner G, Gaynes BN. 2009. Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Med Decis Making 29:91–103.
  • Harbord RM, Whiting P, Sterne JAC, Egger M, Deeks JJ, Shang A, . 2008. An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary. J Clin Epidemiol 61:1095–1103.
  • Hardy RJ, Thompson SG. 1998. Detecting and describing heterogeneity in meta-analysis. Stat Med 17:841–856.
  • Hedges LV, Pigott TD. 2001. The power of statistical tests in meta-analysis. Psychol Methods 6:203–217.
  • Hedges LV, Pigott TD. 2004. The power of statistical tests for moderators in metaanalysis. Psychol Methods 9:426–445.
  • Higgins J, Green S, 2009. Cochrane handbook for systematic reviews of interventions, version 5.0.2. The Cochrane Collaboration.
  • Higgins JPT, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. Br Med J 327:557–560.
  • Higgins JPT, White IR, Wood AM. 2008. Imputation methods for missing outcome data in meta-analysis of clinical trials. Clin Trials 5:225–239.
  • Horder J, Matthews P, Waldmann R. 2010. Placebo, prozac and plos: significant lessons for psychopharmacology. J Psychopharmacol.
  • Ioannidis JPA. 2005. Why most published research findings are false. PLoS Med 2:e124.
  • Jackson D. 2006. The power of the standard test for the presence of heterogeneity in meta-analysis. Stat Med 25: 2688–2699.
  • Jüni P, Witschi A, Bloch R, Egger M. 1999. The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc 282:1054–1060.
  • Kasper S. 2010. The proof of efficacy in psychopharmacology: clinical studies, metaanalysis and evidence-based medicine. Eur Arch Psychiatry Clin Neurosci 260:1.
  • Khan A, Leventhal RM, Khan SR, Brown WA. 2002. Severity of depression and response to antidepressants and placebo: an analysis of the food and drug administration database. J Clin Psychopharmacol 22:40–45.
  • Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. 2008. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med 5:e45.
  • Lambert PC, Sutton AJ, Abrams KR, Jones DR. 2002. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 55: 86–94.
  • Lee WL, Bausell RB, Berman BM. 2001. The growth of health-related meta-analyses published from 1980 to 2000. Eval Health Prof 24:327–335.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, . 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100.
  • Maier W, Möller HJ. 2010. Meta-analyses: a method to maximise the evidence from clinical studies? Eur Arch Psychiatry Clin Neurosci 260:17–23.
  • Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. 2003. Evidence b(i)ased medicine–selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. Br Med J 326:1171–1173.
  • Melander H, Salmonson T, Abadie E, van Zwieten-Boot B. 2008. A regulatory apologia – a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. Eur Neuropsychopharmacol 18:623–627.
  • Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. 1999. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. quality of reporting of meta-analyses. Lancet 354:1896–1900.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097.
  • Möller HJ, Broich K. 2010. Principle standards and problems regarding proof of efficacy in clinical psychopharmacology. Eur Arch Psychiatry Clin Neurosci 260:3–16.
  • Möller HJ, Maier W. 2010. Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci 260:25–39.
  • Patsopoulos NA, Analatos AA, Ioannidis JPA. 2005. Relative citation impact of various study designs in the health sciences. J Am Med Assoc 293:2362–2366.
  • Pearson K. 1904. Report on certain enteric fever inoculation statistics. Br Med J 3:1243–1246.
  • Petticrew M. 2001. Systematic reviews from astronomy to zoology: myths and misconceptions. Br Med J 322:98–101.
  • Robertson C, Idris NRN, Boyle P. 2004. Beyond classical meta-analysis: can inadequately reported studies be included? Drug Discov Today 9:924–931.
  • Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP. 2008. Design makes a difference: a meta-analysis of antidepressant response rates in placebocontrolled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 16:65–73.
  • Stewart LA, Tierney JF. 2002. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 25:76–97.
  • Sutton AJ, Higgins JPT. 2008. Recent developments in meta-analysis. Stat Med 27:625–650.
  • Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. 2006. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 63:1217–1223.
  • Terrin N, Schmid CH, Lau J, Olkin I. 2003. Adjusting for publication bias in the presence of heterogeneity. Stat Med 22: 2113–2126.
  • Thompson SG. 1994. Why sources of heterogeneity in meta-analysis should be investigated. Br Med J 309:1351–1355.
  • Thompson SG, Higgins JPT. 2002. How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559–1573.
  • Tritchler D. 1999. Modelling study quality in meta-analysis. Stat Med 18:2135–2145.
  • Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. 2008. Selective publication of antidepressant trials and its influence on apparent efficacy. New Engl J Med 358:252–260.
  • Walsh BT, Seidman SN, Sysko R, Gould M. 2002. Placebo response in studies of major depression: variable, substantial, and growing. J Am Med Assoc 287:1840–1847.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.